Repeat intrathecal triamcinolone acetonide application is beneficial in progressive MS patients.

MLA

Hoffmann, V., et al. “Repeat Intrathecal Triamcinolone Acetonide Application Is Beneficial in Progressive MS Patients.” European Journal of Neurology, vol. 13, no. 1, Jan. 2006, pp. 72–76. EBSCOhost, https://doi.org/10.1111/j.1468-1331.2006.01145.x.

APA

Hoffmann, V., Kuhn, W., Schimrigk, S., Islamova, S., Hellwig, K., Lukas, C., Brune, N., Pöhlau, D., Przuntek, H., & Müller, T. (2006). Repeat intrathecal triamcinolone acetonide application is beneficial in progressive MS patients. European Journal of Neurology, 13(1), 72–76. https://doi.org/10.1111/j.1468-1331.2006.01145.x

Chicago

Hoffmann, V, W Kuhn, S Schimrigk, S Islamova, K Hellwig, C Lukas, N Brune, D Pöhlau, H Przuntek, and T Müller. 2006. “Repeat Intrathecal Triamcinolone Acetonide Application Is Beneficial in Progressive MS Patients.” European Journal of Neurology 13 (1): 72–76. doi:10.1111/j.1468-1331.2006.01145.x.